Pet Vaccine Market to Grow with a CAGR of 6.04% through 2030
Advancements
in veterinary biotechnology and the growing awareness of pet immunization, is
expected to drive the Global Pet Vaccine Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Pet Vaccine Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global Pet
Vaccine Market stood at USD
11.31 Billion in 2024 and is expected to reach USD 16.10 Billion by
2030 with a CAGR of 6.04% during the forecast period. The global pet vaccine
market is witnessing robust expansion, driven by the increasing prevalence of
infectious diseases in companion animals and the growing emphasis on preventive
veterinary care. Rising pet expenditure and heightened concerns about zoonotic
diseases have encouraged pet owners to prioritize vaccination as a key aspect
of animal healthcare. Advances in vaccine production, including novel adjuvants
and mRNA-based formulations, are enhancing immunization efficacy while
minimizing adverse effects. The surge in pet adoption rates, particularly in
urban areas, has led to higher demand for routine veterinary services, further
boosting vaccine consumption. Efforts by animal health organizations and
veterinary associations to educate pet owners on disease prevention are
strengthening market growth.
Cutting-edge
developments in veterinary immunology are paving the way for more targeted and
long-lasting vaccines. The emergence of subunit and vector-based vaccines is
transforming disease prevention strategies, providing broader protection with
minimal side effects. A rising number of veterinary clinics and pet healthcare
facilities are expanding vaccination outreach, making immunization more
accessible than ever before. The increased focus on feline and exotic pet
vaccines is creating new growth avenues for manufacturers. Regulatory
authorities are imposing stricter quality standards for animal vaccines,
fostering innovation and ensuring market credibility. Collaborations between
veterinary pharmaceutical companies and research institutions are accelerating
the introduction of next-generation vaccines tailored to emerging disease
threats.
Rising
investments in veterinary research and the development of personalized vaccines
present significant opportunities for market expansion. The growing acceptance
of needle-free vaccine delivery systems is expected to improve pet owner
compliance and reduce vaccine hesitancy. The increasing penetration of
telemedicine and digital veterinary services is facilitating better vaccine
tracking and reminders, ensuring timely immunization. Expansion into emerging
markets with rising pet ownership rates offers lucrative prospects for vaccine
manufacturers. The demand for organic and preservative-free vaccines is also
gaining traction, creating niche opportunities for innovation. Strengthening
public-private partnerships to promote mass immunization programs can further
enhance market reach and drive long-term growth.
Browse over XX market data Figures spread through XX Pages and an
in-depth TOC on "Global Pet Vaccine Market”
The Global Pet
Vaccine Market is segmented into animal type, vaccination, mode of
administration, regional distribution, and company.
Based on the Mode
Of Administration, Intranasal Vaccines emerged as the fastest growing segment
in the Global Pet Vaccine Market during the forecast period. This is driven by
their numerous advantages over traditional injectable vaccines. These vaccines
are gaining popularity due to their non-invasive administration, which
eliminates the stress and discomfort associated with injections, making them
particularly suitable for younger, anxious, or difficult-to-handle pets.
Intranasal vaccines also provide a strong mucosal immune response, offering
rapid and localized protection against respiratory infections such as
Bordetella bronchiseptica and canine parainfluenza virus, which are common
among dogs. Rising awareness among pet owners and veterinarians about the
benefits of intranasal vaccines is fueling adoption rates. These vaccines
induce both systemic and mucosal immunity, enhancing overall effectiveness
while reducing the risk of adverse reactions compared to injectable
formulations. Additionally, veterinary professionals favor intranasal
administration as it simplifies the vaccination process and reduces the
likelihood of improper dosing.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Pet Vaccine Market during
the forecast period. This is driven by rising pet ownership, increasing
disposable income, and growing awareness of animal healthcare. Countries like
China, India, Japan, and South Korea are witnessing a surge in pet adoption,
particularly among the middle-class population, leading to greater demand for
pet healthcare services, including vaccination. The rising prevalence of
zoonotic diseases and government initiatives promoting compulsory pet
immunization are further accelerating market growth. The region’s expanding
veterinary infrastructure, coupled with increasing investments by global and
regional vaccine manufacturers, is enhancing accessibility to advanced pet
vaccines. Veterinary clinics and pet hospitals are expanding their service offerings,
making vaccination more widely available. Additionally, the growing pet
insurance sector in Asia-Pacific is encouraging pet owners to invest in
preventive healthcare, including routine immunization.
Technological
advancements in vaccine development and the introduction of novel biologics and
recombinant vaccines are supporting the market’s expansion. The shift in
consumer perception toward pet humanization is also driving demand for
high-quality veterinary care, contributing to the rapid growth of the pet
vaccine market in Asia-Pacific. As awareness and affordability continue to
rise, the region is expected to maintain its position as the fastest-growing
market in the coming years.
Major
companies operating in Global Pet Vaccine Market are:
- Bayer
AG
- Elanco
US Inc.
- Merck
KGaA
- Merial
Inc.
- Virbac
SA
- Zoetis
Inc
- Phibro
Animal Health Corporation
- Boehringer
Ingelheim GmbH
- Tianjin
Ringpu Bio-Technology Co., Ltd
- Vetoquinol
SA
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Pet
Vaccine Market is expanding due to the increasing adoption of pet insurance,
which incentivizes pet owners to prioritize vaccination as part of preventive
healthcare coverage, alongside the growing demand for advanced and combination
vaccines that offer protection against multiple diseases with a single dose.
This trend is further supported by heightened awareness about the risks of
infectious diseases in pets and the rising emphasis on responsible pet
ownership. These factors are driving the demand for dog vaccines across both
developed and emerging markets, contributing to the market's growth.,” said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Pet Vaccine Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By
Animal Type (Canine, Feline, Equine), By Vaccination (Canine Family, Feline
Family, Others), By Mode Of Administration (Injectable Vaccines, Intranasal
Vaccines), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Pet Vaccine Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Pet Vaccine Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com